The Chicago Entrepreneur

Moderna shares fall despite promising data from cancer vaccine trial

Moderna’s mRNA vaccine, when combined with Merck’s blockbuster drug Keytruda, showed promise in treating melanoma, a kind of skin cancer.

Previous post Investor buzz grows as new 30x meme coin presale surpasses $1.1 million raised in first month
Next post : Eli Lilly to invest another $1.6 billion, add 200 more jobs to its new manufacturing sites in Indiana